Romina Lomonaco, MD

Romina Lomonaco, MD

(352) 273-8655

Current patients:
Log in to MyUFHealth

Publications

Intact Fasting Insulin Identifies Nonalcoholic Fatty Liver Disease in Patients Without Diabetes.
The Journal of clinical endocrinology and metabolism
2021

Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic Screening.
Diabetes care
2021

Change in hepatic fat content measured by MRI does not predict treatment-induced histological improvement of steatohepatitis.
Journal of hepatology
2020

Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial.
Diabetes care
2019

Effect of pioglitazone on bone mineral density in patients with nonalcoholic steatohepatitis: A 36-month clinical trial.
Journal of diabetes
2019

Response to Pioglitazone in Patients With Nonalcoholic Steatohepatitis With vs Without Type 2 Diabetes.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
2018

Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver disease.
Hepatology (Baltimore, Md.)
2017

Liver Safety of Statins in Prediabetes or T2DM and Nonalcoholic Steatohepatitis: Post Hoc Analysis of a Randomized Trial.
The Journal of clinical endocrinology and metabolism
2017

Plasma thyroid hormone concentration is associated with hepatic triglyceride content in patients with type 2 diabetes.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research
2016

Metabolic Impact of Nonalcoholic Steatohepatitis in Obese Patients With Type 2 Diabetes.
Diabetes care
2016

Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus: A Randomized Trial.
Annals of internal medicine
2016

Hepatic Steatosis and Insulin Resistance, But Not Steatohepatitis, Promote Atherogenic Dyslipidemia in NAFLD.
The Journal of clinical endocrinology and metabolism
2016

The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease.
Hepatology (Baltimore, Md.)
2015

Relationship of vitamin D with insulin resistance and disease severity in non-alcoholic steatohepatitis.
Journal of hepatology
2015

Relationship of Vitamin D With Insulin Resistance and Disease Severity in Non-Alcoholic Steatohepatitis

2015

High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels.
The Journal of clinical endocrinology and metabolism
2015

Clinical value of liver ultrasound for the diagnosis of nonalcoholic fatty liver disease in overweight and obese patients.
Liver international : official journal of the International Association for the Study of the Liver
2015

Relationship between disease severity, hyperinsulinemia, and impaired insulin clearance in patients with nonalcoholic steatohepatitis.
Hepatology (Baltimore, Md.)
2014

Pharmacodynamic Association of Pioglitazone and Its Active Metabolites With Liver Outcomes Among Patients Diagnosed With Nonalcoholic Steatohepatitis.
Clinical Pharmacology & Therapeutics
2014

Multivariate Analysis of Factors That Influence Improvement in Nonalcoholic Fatty Liver Disease (Nafld) After Pioglitazone Treatment.
Pharmacotherapy
2014

Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with non-alcoholic fatty liver disease.
Journal of hepatology
2014

High Prevalence of Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels.
The Journal of clinical endocrinology and metabolism
2014

The future of thiazolidinedione therapy in the management of type 2 diabetes mellitus.
Current diabetes reports
2013

Plasma Branch Chain and Aromatic Amino Acid Levels Are Associated With Insulin Resistance in Nonalcoholic Fatty Liver Disease (Nafld)
The FASEB's Journal
2013

Nonalcoholic fatty liver disease: current issues and novel treatment approaches.
Drugs
2013

The Challenge of Managing Dyslipidemia in Patients With Nonalcoholic Fatty Liver Disease
Clinical Lipidology
2012

Prevalence of prediabetes and diabetes and metabolic profile of patients with nonalcoholic fatty liver disease (NAFLD).
Diabetes care
2012

Metabolic and Histological Effects of Liver Fat Accumulation in Patients With Nash
Higher Education Policy
2012

Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease.
Hepatology (Baltimore, Md.)
2012

Role of ethnicity in overweight and obese patients with nonalcoholic steatohepatitis.
Hepatology (Baltimore, Md.)
2011

An endocrine perspective of nonalcoholic fatty liver disease (NAFLD)

2011

An Endocrine Perspective of Nonalcoholic Fatty Liver Disease (NAFLD).
Therapeutic advances in endocrinology and metabolism
2011

Research Interests

Romina Lomonaco, M.D. has been involved in clinical research in adult endocrinology, mainly in the metabolism field. She has participated in clinical trials related to Type 2 diabetes associated to nonalcoholic fatty liver disease, or NAFLD. Her current research interest focuses in understanding the metabolic impact that NAFLD, and specifically its more severe form nonalcoholic steatohepatitis, or NASH, has in patients with Type 2 diabetes and/or obesity. She has also been involved in clinical trials assessing different drugs that could potentially be used to treat this condition.

Dr. Lomonaco has numerous publications including original articles, reviews and book chapters in the main journals in the fields of diabetes, obesity and liver disease.

She specializes in treating patients with diabetes and other metabolic diseases such as dyslipidemia and obesity.